359 related articles for article (PubMed ID: 25387566)
1. Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
Liu Y; Yun X; Gao M; Yu Y; Li X
Clin Transl Oncol; 2015 Apr; 17(4):274-80. PubMed ID: 25387566
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
[TBL] [Abstract][Full Text] [Related]
3. T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.
Zhu C; Dai Y; Zhang H; Ruan Y; Zhou Y; Dai Y; Fan L; Jia T; Lu H; Chen Q
Diagn Pathol; 2021 Aug; 16(1):84. PubMed ID: 34465342
[TBL] [Abstract][Full Text] [Related]
4. [Studies about the level of CD4+ CD25+ regulatory T cells and relation between expression of Foxp3 and CD127 in peripheral blood of chronic HBV infection].
Deng M; Li MH; Liu SA; Liu F; Sang Y; Song SJ; Zang SF; Guan XP; Yao X; Wu XP; Cheng J; Xu DZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):21-3. PubMed ID: 20848841
[TBL] [Abstract][Full Text] [Related]
5. [Role of CD4+ CD25+ regulatory T cells in peripheral blood from patients with papillary thyroid carcinoma].
Shi J; Zhou J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Nov; 26(21):965-9, 972. PubMed ID: 23373232
[TBL] [Abstract][Full Text] [Related]
6. Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.
Bossowski A; Moniuszko M; Dąbrowska M; Sawicka B; Rusak M; Jeznach M; Wójtowicz J; Bodzenta-Lukaszyk A; Bossowska A
Autoimmunity; 2013 May; 46(3):222-30. PubMed ID: 23249428
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.
French JD; Weber ZJ; Fretwell DL; Said S; Klopper JP; Haugen BR
J Clin Endocrinol Metab; 2010 May; 95(5):2325-33. PubMed ID: 20207826
[TBL] [Abstract][Full Text] [Related]
8. Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?
Divani SN; Kalodimos GP; Lioupis MA; Syrmos NC
Hell J Nucl Med; 2016; 19(3):250-253. PubMed ID: 27824965
[TBL] [Abstract][Full Text] [Related]
9. SIRT1-Regulated Abnormal Acetylation of FOXP3 Induces Regulatory T-Cell Function Defect in Hashimoto's Thyroiditis.
Yang X; Lun Y; Jiang H; Liu X; Duan Z; Xin S; Zhang J
Thyroid; 2018 Feb; 28(2):246-256. PubMed ID: 29336238
[TBL] [Abstract][Full Text] [Related]
10. FoxP3 promotes lymph node metastasis in patients with papillary thyroid carcinoma complicated with Hashimoto's thyroiditis.
Zeng R; Lyu Y; Niu H; Yang K; Yan X
Transl Cancer Res; 2020 Mar; 9(3):1337-1350. PubMed ID: 35117482
[TBL] [Abstract][Full Text] [Related]
11. Decreased proportions of CD4 + IL17+/CD4 + CD25 + CD127- and CD4 + IL17+/CD4 + CD25 + CD127 - FoxP3+ T cells in children with autoimmune thyroid diseases (.).
Bossowski A; Moniuszko M; Idźkowska E; Grubczak K; Singh P; Bossowska A; Diana T; Kahaly GJ
Autoimmunity; 2016 Aug; 49(5):320-8. PubMed ID: 27206624
[TBL] [Abstract][Full Text] [Related]
12. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
[TBL] [Abstract][Full Text] [Related]
13. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
14. The expression and significance of CD4+CD25+CD127low/- regulatory T cells and Foxp3 in patients with portal hypertension and hypersplenism.
Guo Y; Wu CZ; Liao Y; Zhang QY
Hepatogastroenterology; 2013 May; 60(123):581-4. PubMed ID: 23282736
[TBL] [Abstract][Full Text] [Related]
15. High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.
Dong S; Xia Q; Wu YJ
Otolaryngol Head Neck Surg; 2015 Jul; 153(1):20-6. PubMed ID: 25917667
[TBL] [Abstract][Full Text] [Related]
16. Dioscin alleviates hashimoto's thyroiditis by regulating the SUMOylation of IRF4 to promote CD4
Yongjun C; Nan Q; Yumeng S; Xiaowen J; Weibo W
Autoimmunity; 2021 Feb; 54(1):51-59. PubMed ID: 33274645
[TBL] [Abstract][Full Text] [Related]
17. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
18. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK
Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
[TBL] [Abstract][Full Text] [Related]
19. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of CCR6, CCR7 and CD4(+)CD25(+) Foxp3(+) regulatory T cells in laryngeal squamous cell carcinoma and neck lymphatic metastasis].
Chen B; Lu LM; Tao L; Zhou L; Li SM; Zhu L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 45(9):759-64. PubMed ID: 21092675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]